Phase I Clinical Trial To Test Combination Of Two HIV Vaccine Candidates Starts In London
Thursday, November 27, 2008 - 09:22
in Health & Medicine
Researchers have initiated a Phase I clinical trial in London, UK to test a prime-boost combination of two HIV vaccine candidates. The news follows promising results for one of the two vaccine candidates to be tested, the MVA-based TBC-M4, which in a recent phase I trial generated modest immune responses in all volunteers who received the highest dose.